• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIVANOVA USA, INC. LEAD MODEL 304

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIVANOVA USA, INC. LEAD MODEL 304 Back to Search Results
Model Number 304-30
Device Problem Fracture (1260)
Patient Problems Pain (1994); No Code Available (3191)
Event Date 09/16/2017
Event Type  malfunction  
Event Description
Report received that a patient's vns was interrogated and high impedance was observed.The patient reported that he stopped feeling stimulation four months prior to this observation.It was reported that trauma was not suspected to have contributed to the high impedance.No surgical interventions have occurred to date.No further relevant information has been received.
 
Event Description
It was reported that the patient was feeling a shocking sensation in his chest, so the physician programmed the device off.No surgery has occurred to date.
 
Event Description
Patient underwent generator replacement surgery.The explanted generator has not been received by the manufacturer to date.The patient also reported that he has been tazed repeatedly with a 50,000 watt tazer and due to excessive force he felt his generator break.No known surgical intervention has occurred with the suspect product (lead) to date.No other relevant information has been received to date.
 
Event Description
Explanted generator was received by the manufacturer.Product analysis completed on the returned generator.The electrical tests performed in the pa lab found that the generator was at an ifi = no condition.The battery voltage was measured at 2.915 volts, and the memory locations on the generator indicated that 56.995% of the battery had been consumed.The generator underwent 24 hour monitoring in a simulated body temperature environment.There were no variations in the output signal, the device supplied the expected level of output current during the entire period and diagnostics were as expected.The magnet activations performed confirmed that the appropriate magnet output for the programmed settings.There were no performance or any other type of adverse conditions found with the pulse generator, and the pulse generator performed according to functional specifications.No other relevant information has been received to date.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LEAD MODEL 304
Type of Device
LEAD
Manufacturer (Section D)
LIVANOVA USA, INC.
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
LIVANOVA USA, INC.
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
rachel kohn
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key7261480
MDR Text Key99954315
Report Number1644487-2018-00194
Device Sequence Number1
Product Code LYJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date 03/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date04/10/2018
Device Model Number304-30
Device Lot Number202921
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Event Location Other
Date Manufacturer Received02/11/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/07/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age34 YR
-
-